CARGO Therapeutics (NASDAQ:CRGX) Downgraded to Neutral Rating by Chardan Capital
CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by stock analysts at Chardan Capital from a “buy” rating to ...
CARGO Therapeutics (NASDAQ:CRGX) Lowered to Neutral Rating by HC Wainwright
CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by stock analysts at HC Wainwright from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on ...
Fintel on MSN2d
Chardan Capital Downgrades CARGO Therapeutics (CRGX)
Fintel reports that on January 30, 2025, Chardan Capital downgraded their outlook for CARGO Therapeutics (NasdaqGS:CRGX) from ...
Cargo Therapeutics downgraded to Neutral from Buy at Chardan
Chardan downgraded Cargo Therapeutics (CRGX) to Neutral from Buy without a price target The company will be discontinuing the Phase II FIRCE-1 ...
Chardan Capital downgrades CARGO Therapeutics, Inc. (CRGX) to a Hold
CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from Chardan Capital analyst Geulah Livshits ...
DFLI stock touches 52-week low at $2.13 amid market challenges
In a challenging market environment, shares of Chardan Nextech Acquisition 2 (DFLI) have reached a 52-week low, dipping to $2.13. The company, which has been navigating through a turbulent financial ...